Literature DB >> 9783553

Parathyroid hormone-related protein mRNA and protein expression in multiple myeloma: a case report.

H G Schneider1, V Kartsogiannis, H Zhou, S T Chou, T J Martin, V Grill.   

Abstract

Multiple myeloma frequently leads to complications, such as osteolytic lesions, hypercalcemia, and pathological fractures. Increased bone resorption in myeloma is due to osteoclast activation. The nature of the osteoclast activator(s) remains unclear. We describe a case of multiple myeloma with marked hypercalcemia and skeletal complications that progressed rapidly despite chemotherapy. The patient had marked hypercalcemia at diagnosis (4.5 mmol/l), and elevated parathyroid hormone-related protein (PTHrP) levels were found in plasma. Analysis of the bone marrow trephine biopsy showed PTHrP gene transcription and protein in myeloma cells. These results provide strong evidence for the production of significant amounts of PTHrP by human myeloma cells. PTHrP has been measured as elevated in the plasma of patients with myeloma and might be an important contributor to the skeletal complications in this disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9783553     DOI: 10.1359/jbmr.1998.13.10.1640

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  3 in total

Review 1.  Hypercalcemia of malignancy.

Authors:  V Grill; T J Martin
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Increase in serum 1,25-dihydroxyvitamin D and hypercalcaemia in a patient with inflammatory myofibroblastic tumour.

Authors:  A Ogose; H Kawashima; O Morita; T Hotta; H Umezu; N Endo
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

Review 3.  Treatment of malignancy-associated hypercalcemia with cinacalcet: a paradigm shift.

Authors:  Sondra O'Callaghan; Hanford Yau
Journal:  Endocr Connect       Date:  2021-01       Impact factor: 3.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.